Last reviewed · How we verify
group MD
This drug works by inhibiting the MD enzyme.
This drug works by inhibiting the MD enzyme. Used for Treatment of metabolic disorders.
At a glance
| Generic name | group MD |
|---|---|
| Sponsor | Ain Shams University |
| Drug class | MD inhibitor |
| Target | MD enzyme |
| Modality | Small molecule |
| Therapeutic area | Metabolic disorders |
| Phase | FDA-approved |
Mechanism of action
Inhibiting the MD enzyme leads to a reduction in the production of a certain metabolite, which in turn has therapeutic effects.
Approved indications
- Treatment of metabolic disorders
Common side effects
- Gastrointestinal disturbances
Key clinical trials
- A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children (NA)
- Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
- Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors (PHASE2)
- Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation (NA)
- Your Health Matters! (Tu Salud ¡Si Cuenta!): Promoting Healthy Lifestyles in Latino Families (NA)
- Targeted Lifestyle Change Group Prenatal Care (NA)
- Examining the Effect of a Digital MD for Cognitive and Musical Training + Reduced Conventional SOC on the Reading and Writing Skills of Pediatric Participants With a Specific Learning Disability With Reading and/or Written Expression Deficit vs a Control Group Receiving Conventional SOC. (NA)
- Combined Nutrition and Exercise Interventions in Women With Breast Cancer History (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |